Skip to main content

Kaare Bjerregaard-Andersen, PhD

Senior Research Scientist at H. Lundbeck A/S

Location: 2500 Valby Denmark

Kaare Bjerregaard-Andersen, PhD, received a doctorate from Oslo University, where he worked to characterize membrane protein structure, specifically regions of intrinsic disorder within a regulatory region of a bicarbonate transporter protein. He also developed an enzymatic assay for a isatin, a product of amino acid metabolism, to facilitate its development as a biomarker. As a postdoctoral fellow at Oslo University (2014-2018), Dr. Bjerregaard-Anderson continued working on protein structures, with a focus on engineering an antibody that can recognize a tumor-associated surface sugar. At Lundbeck (Copenhagen, Denmark) since 2018, he is focused on alpha-synuclein structural biology and pathology, developing a seed amplification assay (SAA) for detecting aggregated alpha-synuclein as a biomarker, and he is a project leader on an early program to develop pathology-specific antibodies.

Associated Grants

  • Maximizing the Sensitivity of Seed Amplification Assays Used to Detect Alpha-synuclein Aggregates


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.